▶ 調査レポート

免疫グロブリンの世界市場分析・規模・シェア・成長・動向・予測:用途別(神経学、免疫学、血液学)、投与経路(静脈内、皮下、筋肉内)、ユーザー別(病院、診療所、在宅)

• 英文タイトル:Immunoglobulins Market (Applications - Neurology, Immunology, Hematology; Route of Administration - Intravenous, Subcutaneous, Intramuscular; End user - Hospital, Clinic, Homecare) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transparency Market Researchが調査・発行した産業分析レポートです。免疫グロブリンの世界市場分析・規模・シェア・成長・動向・予測:用途別(神経学、免疫学、血液学)、投与経路(静脈内、皮下、筋肉内)、ユーザー別(病院、診療所、在宅) / Immunoglobulins Market (Applications - Neurology, Immunology, Hematology; Route of Administration - Intravenous, Subcutaneous, Intramuscular; End user - Hospital, Clinic, Homecare) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 / TPM-C02078資料のイメージです。• レポートコード:TPM-C02078
• 出版社/出版日:Transparency Market Research / 2018年12月24日
• レポート形態:英文、PDF、188ページ
• 納品方法:Eメール
• 産業分類:Pharmaceutical
• 販売価格(消費税別)
  Single User¥625,860 (USD5,795)▷ お問い合わせ
  Multi User¥949,860 (USD8,795)▷ お問い合わせ
  Global Site License¥1,273,860 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、免疫グロブリンの世界市場について調べ、免疫グロブリンの世界規模、市場動向、市場環境、用途別(神経学、免疫学、血液学)分析、投与経路(静脈内、皮下、筋肉内)分析、ユーザー別(病院、診療所、在宅)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・免疫グロブリンの世界市場動向
・免疫グロブリンの世界市場環境
・免疫グロブリンの世界市場規模
・免疫グロブリンの世界市場規模:用途別(神経学、免疫学、血液学)
・免疫グロブリンの世界市場規模:投与経路(静脈内、皮下、筋肉内)
・免疫グロブリンの世界市場規模:ユーザー別(病院、診療所、在宅)
・免疫グロブリンの世界市場:地域別市場規模・分析
・免疫グロブリンの北米市場規模・予測
・免疫グロブリンのアメリカ市場規模・予測
・免疫グロブリンの中南米市場規模・予測
・免疫グロブリンのヨーロッパ市場規模・予測
・免疫グロブリンのアジア市場規模・予測
・免疫グロブリンの日本市場規模・予測
・免疫グロブリンの中国市場規模・予測
・免疫グロブリンのインド市場規模・予測
・免疫グロブリンの中東市場規模・予測
・免疫グロブリンのアフリカ市場規模・予測
・競争状況・関連企業情報

Global Immunoglobulins Market: Overview

This report analyzes the current and future scenario of the global immunoglobulins market for the period 2018 to 2026. Rise in neurology, immunology, hematology, and other disease prevalence, high unmet medical needs, and rich pipeline are likely to be major drivers of the global immunoglobulins market during the forecast period.

The global immunoglobulins market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on applications, route of administration, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global immunoglobulins market.

Global Immunoglobulins Market: Key Segments

Based on application, the global immunoglobulins market has been segmented into neurology, immunology, hematology, and others. The segments have been analyzed based on available products used during the treatment of chronic diseases, and cost-effectiveness. In terms of route of administration, the global immunoglobulins market has been classified into intravenous, subcutaneous, and intramuscular. Based on end-user, the global immunoglobulins market has been divided into hospital, clinics, and homecare. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Global Immunoglobulins Market: Regional Outlook

In terms of region, the global immunoglobulins market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global Immunoglobulins market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Shire, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc, Biotest AG, Sanquin, and LFB SA.

The global immunoglobulins market has been segmented as below:

Global Immunoglobulins Market, by Applications
Neurology
Immunology
Hematology
Others
Global Immunoglobulins Market, by Route Of Administration
Intravenous
Subcutaneous
Intramuscular
Global Immunoglobulins Market, by End-user
Hospital
Clinic
Homecare
Global Immunoglobulins Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Immunoglobulins Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Immunoglobulins Market Analysis and Forecast, 2016–2026
4.4.1. Global Immunoglobulins Market Value (US$ Mn) Projections
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis

6. Global Immunoglobulins Market Analysis and Forecast, by Applications
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2016–2026
6.3.1. Neurology
6.3.2. Immunology
6.3.3. Hematology
6.3.4. Others
6.4. Global Immunoglobulins Market Attractiveness by Applications

7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
7.3.1. Intravenous
7.3.2. Subcutaneous
7.3.3. Intramuscular
7.4. Global Immunoglobulins Market Attractiveness by Route of Administration

8. Global Immunoglobulins Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospital
8.3.2. Clinic
8.3.3. Homecare
8.4. Global Immunoglobulins Market Attractiveness by End-user

9. Global Immunoglobulins Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Immunoglobulins Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Immunoglobulins Market Attractiveness, by Country/Region

10. North America Immunoglobulins Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
10.2.1. Neurology
10.2.2. Immunology
10.2.3. Hematology
10.2.4. Others
10.3. North America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
10.3.1. Intravenous
10.3.2. Subcutaneous
10.3.3. Intramuscular
10.4. North America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Homecare
10.5 North America Immunoglobulins Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada
10.6. North America Immunoglobulins Market Attractiveness Analysis
10.6.1. By Applications
10.6.2. By Route of Administration
10.6.3. By End-user
10.6.4. By Country

11. Europe Immunoglobulins Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Immunoglobulins Market Value Forecast by Applications, 2016–2026
11.2.1. Neurology
11.2.2. Immunology
11.2.3. Hematology
11.2.4. Others
11.3. Europe Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
11.3.1. Intravenous
11.3.2. Subcutaneous
11.3.3. Intramuscular
11.4. Europe Immunoglobulins Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Homecare
11.5. Europe Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Immunoglobulins Market Attractiveness Analysis
11.6.1. By Applications
11.6.2. By Route of Administration
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Pacific Immunoglobulins Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Immunoglobulins Market Value Forecast, by Applications, 2016–2026
12.2.1. Neurology
12.2.2. Immunology
12.2.3. Hematology
12.2.4. Others
12.3. Asia Pacific Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
12.3.1. Intravenous
12.3.2. Subcutaneous
12.3.3. Intramuscular
12.4. Asia Pacific Immunoglobulins Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Homecare
12.5. Asia Pacific Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Immunoglobulins Market Attractiveness Analysis
12.6.1. By Applications
12.6.2. By Route of Administration
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Immunoglobulins Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
13.2.1. Neurology
13.2.2. Immunology
13.2.3. Hematology
13.2.4. Others
13.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
13.3.1. Intravenous
13.3.2. Subcutaneous
13.3.3. Intramuscular
13.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Homecare
13.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immunoglobulins Market Attractiveness Analysis
13.6.1. By Applications
13.6.2. By Route of Administration
13.6.3. By End-user
13.6.4. By Country/Sub-region

14. Middle East & Africa Immunoglobulins Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
14.2.1. Neurology
14.2.2. Immunology
14.2.3. Hematology
14.2.4. Others
14.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
14.3.1. Intravenous
14.3.2. Subcutaneous
14.3.3. Intramuscular
14.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospital
14.4.2. Clinic
14.4.3. Homecare
14.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Latin America Immunoglobulins Market Attractiveness Analysis
14.6.1. By Applications
14.6.2. By Route of Administration
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share Analysis by Company (2016)
15.3. Company Profiles
15.3.1. Shire
15.3.2. CSL Behring
15.3.3. Kedrion Biopharma Inc
15.3.4. Grifols, S.A.
15.3.5. Octapharma
15.3.6. China Biologic Products Holdings, Inc
15.3.7. Biotest AG
15.3.8. Sanquin
15.3.9. LFB SA

List of Tables

Table 01: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 02: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 03: Global Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 06: North America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 07: North America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 08: North America Immunoglobulins Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 09: Europe Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 10: Europe Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 11: Europe Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 14: Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 15: Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Latin America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 18: Latin America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 19: Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 22: Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 23: Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026